In a bid to push manufacturers to reduce their greenhouse gas
emissions, the UK government last week unveiled a proposal that
could pave the way for "carbon footprint" labels on products.
Schreiner MediPharm, a leading manufacturer of 'intelligent' labels
has chosen Datalase's flagship Packmark printing technique for its
customers in the pharma industry.
Amgen will strengthen its drug portfolio aimed at fighting renal
disease after agreeing to acquire Ilypsa, a private biotechnology
company which is developing a novel drug for the treatment of
elevated blood phosphate (hyperphosphataemia)...
Thermo Fisher Scientific has introduced a range of powerful new
mass spectroscopy products at the 55th ASMS Conference on Mass
Spectrometry currently being held in Indianapolis, US.
DeltaDOT has been given a government grant to commercially develop
a new tool to allow researchers to reduce dramatically the time it
takes to weed out unsuitable drug candidates.
Veeda Clinical Research, an Anglo-Indian contract research
organisation (CRO) formed two years ago, said it will soon enter
the US market with a new acquisition - the fourth since the
company's creation.
Switzerland-based Roche is helping African nations fight the AIDS
epidemic by sharing its coveted saquinavir drug-producing
technology with two more manufacturers in Ethiopia and Zimbabwe.
Japanese researchers have developed a high throughput method for
screening the activity of beta-amyloid protein aggregation
inhibitors that should speed up the discovery of new Alzheimer's
therapies.
Germany's Capsulution Nanoscience is tapping into Qiagen's
molecular diagnostics expertise in a collaboration that will
explore new diagnostic and therapeutic possibilities for cancer and
other diseases.
British drug maker AstraZeneca has awarded UK-based NYK Logistics a
two and a half year contract for the distribution of its drugs
throughout Europe, worth £6m (€8.9m).
The European Commission has released figures showing that there has
been a dramatic and concerning increase in pharmaceutical
counterfeiting, with seizures in Europe hitting an all time high of
over 2.5m items.
Analysing the images from protein separation experiments, such as
2D gel electrophoresis (2DGE), is not only time consuming but can
often miss 'hits' and give false positives. But it doesn't have to
be that way, according...
Pfizer is facing fresh legal action from the Nigerian government
over its alleged involvement in the deaths of children it gave
an experimental drug to, more than a decade after the incident
occurred.
Ineos Films is expanding capabilities at its flagship US plant to
try and grab a slice of the PVC blister film market from the
dominant figure Klockner.
Two firms have announced a licence and supply agreement for a novel
formulation of valproic acid presented as a softgel capsule, which
could challenge Abbott's top selling drug Depakote (divalproex
sodium).
A magic bullet for the pharmaceutical supply chain has entered the
stage as radio frequency identification (RFID) technology attempts
to fix up its teething problems.
ADInstruments has launched its Neuro Amp EX to improve neurological
data collection from animals and humans during drug candidate
testing by reducing noise and improving ease of use.
A fund to promote biotech collaborations between Australia and New
Zealand has awarded a lump sum to two Antipodean firms which will
result in a new good manufacturing practice (GMP) compliant peptide
manufacturing plant in the under-served...
Danish firm Novozymes has launched its first range of animal-free
recombinant cell culture ingredients from its new business unit in
the UK, offering biopharmaceutical firms an alternative to
traditional serum-based production methods.
MDS Pharma has decided to continue the 'consolidation' of its
Canadian operations by putting an end to some activities at its
Montreal facility, cutting 160 jobs.
The fine chemicals division of Japanese contract manufacturer Daiso
has taken out a license to a highly-selective technology used to
synthesise chiral molecules.
Alcan Packaging Kreuzlingen is the latest company to receive
certification for the new ISO standard for primary packaging,
becoming the first flexible packaging firm in the world to achieve
the accreditation.
The latest ethical reputations of the world's largest
pharmaceutical companies have been revealed, with GlaxoSmithKline
(GSK) emerging as big pharma's Mother Theresa, according to a
recently-released compilation by Geneva-based...
CellCyte Genetics, Whatman, Nektar Therapeutics, Anesiva and
Hyaluron Contract Manufacturing have all had people on the move in
the world of pharmaceutical manufacturing.
Biopharma firm Vivalis has announced several licence agreements for
its proprietary cell line technology, adding to the list of
companies applying the technology to develop and commercialise new
human influenza vaccines.
Over 50 per cent of proteins in the body are considered too
difficult to target with drugs; they are 'undruggable'. Yet it is
exactly these molecules US pharma firm Avalon is focussing on.
Scientists who have genetically engineered mice to be more
intelligent, claim the results could lead to new treatments for
Alzheimer's, post-traumatic stress disorder or drug addiction.
With Asia increasingly becoming the destination of choice for
manufacturers and the domestic market blossoming, a major
components manufacturer has singled out its Singapore facility for
a multi-million dollar expansion.
China has today sentenced to death the former director of its State
Food and Drug Administration (SFDA), on charges of corruption,
according to reports in the Chinese media.
An oral formulation of salmon calcitonin based on Emisphere
Technologies' eligen delivery system has entered Phase III clinical
trials for the treatment of osteoarthritis.
Suppressing granulocyte macrophage colony-stimulating factor
(GM-CSF) to tackle inflammatory and autoimmune diseases is the
concept behind a new worldwide collaboration between
German-American biopharmaceutical company Micromet and...
The National Institute of Standards and Technology (NIST) has
issued its first ever reference material to improve the performance
and reliability of proteomics research.
Batches of two fake blockbuster drugs are being recalled after
counterfeits made their way into the UK supply chain via parallel
distribution, adding fuel to the debate on the security of the
practice in the EU.
US-based contract research organisation (CRO) Covance is offering
microdosing studies for early clinical development without the
perceived drawbacks of having to radiolabel compounds for detection
through ultra-sensitive accelerator...
